Page last updated: 2024-08-23

simvastatin and Coagulation Disorders, Blood

simvastatin has been researched along with Coagulation Disorders, Blood in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Du, MY; Hu, Y; Luo, LL; Mei, H; Tang, L; Xu, M; Zhou, J1
Audebert, H; Haberl, RL1
Neild, GH1
Bauer, EP; Haberbosch, W; Hilgendorff, A; Hölschermann, H; Kemkes-Matthes, B; Schönburg, M; Tillmanns, H1

Reviews

1 review(s) available for simvastatin and Coagulation Disorders, Blood

ArticleYear
[Secondary prevention after stroke: healthy life style, oral anticoagulation].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Administration, Oral; Adult; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Blood Coagulation Disorders; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Clinical Trials as Topic; Contraceptives, Oral; Embolism; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Ischemic Attack, Transient; Life Style; Male; Phenprocoumon; Platelet Aggregation Inhibitors; Recurrence; Simvastatin; Smoking Cessation; Stroke

2003

Other Studies

3 other study(ies) available for simvastatin and Coagulation Disorders, Blood

ArticleYear
Simvastatin Improves Outcomes of Endotoxin-induced Coagulopathy by Regulating Intestinal Microenvironment.
    Current medical science, 2022, Volume: 42, Issue:1

    Topics: Animals; Blood Coagulation Disorders; Disease Models, Animal; Endotoxemia; Endotoxins; Gastrointestinal Microbiome; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Diseases; Male; Mice; Mice, Inbred C57BL; Simvastatin

2022
Statins for all.
    Transplantation, 2000, May-15, Volume: 69, Issue:9

    Topics: Blood Coagulation; Blood Coagulation Disorders; Coronary Disease; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin

2000
Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients.
    Transplantation, 2000, May-15, Volume: 69, Issue:9

    Topics: Adult; Aged; Blood Coagulation Disorders; Coronary Disease; Female; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Monocytes; RNA, Messenger; Simvastatin; Thromboplastin

2000